Procédé de préparation de dérivés actifs d'acétoxime

1453921 Psychotropic compositions LABAZ 23 May 1975 [25 June 1974] 22744/75 Heading A5B [Also in Division C2] Pharmaceutical and veterinary compositions having tranquillizing, antidepressant, myorelaxant, anticonvulsant, anxiolytic and sedative activity comprise as an essential active ingredient at...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ALAIN BENOIT-GUYOD, PIERRE LUC EYMARD, MADELEINE BROLL, LOUIS BOUCHERLE, ANDRE BOUCHERLE, GEORGES BOUCHERLE, MARCEL TAILLANDIER, JEAN-LOUIS GUYOD
Format: Patent
Sprache:fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1453921 Psychotropic compositions LABAZ 23 May 1975 [25 June 1974] 22744/75 Heading A5B [Also in Division C2] Pharmaceutical and veterinary compositions having tranquillizing, antidepressant, myorelaxant, anticonvulsant, anxiolytic and sedative activity comprise as an essential active ingredient at least one acetoxine derivative represented by the general formula wherein R 1 , R 2 and R 3 , which may be the same or different, each represent a branched- or straight-chain C 1-4 alkyl group or R 1 and R 2 , when taken together, represent with the carbon atom to which they are attached a cyclohexyl radical, in association with a pharmaceutical carrier or excipient therefor. The compositions may be administered orally, parenterally or rectally in the form of tablets, capsules, suspensions, syrups, suppositories and solutions.